Question · QUESTION_WRITTEN
E-10-2025-002229
Veiligheid van geneesmiddelen die via een noodhandelsvergunning op de markt zijn toegelaten
Original
Introduced
4 June 2025
Last action
22 August 2025 · Answer
Status
answered
Sponsors
Ton DIEPEVEEN
Subjects
Discovery layer
Source updated
22 August 2025
Timeline
4 June 2025
Written question
Veiligheid van geneesmiddelen die via een noodhandelsvergunning op de markt zijn toegelaten
Source: QUESTION_WRITTEN
22 August 2025
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Safety of medicines authorised on the market by means of an emergency marketing authorisation
QUESTION_WRITTEN · EN · 13 June 2025
Safety of medicines authorised on the market by means of an emergency marketing authorisation
QUESTION_WRITTEN · EN · 13 June 2025
Answer
QUESTION_WRITTEN_ANSWER · 22 August 2025
Veiligheid van geneesmiddelen die via een noodhandelsvergunning op de markt zijn toegelaten
QUESTION_WRITTEN · NL · 13 June 2025
Veiligheid van geneesmiddelen die via een noodhandelsvergunning op de markt zijn toegelaten
QUESTION_WRITTEN · NL · 13 June 2025
Sponsors
- Ton DIEPEVEEN · AUTHOR
- · COM · ADDRESSEE
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-10-2025-002229_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-10-2025-002229
- eu · E-10-2025-002229 · source updated 22 August 2025